Literature DB >> 22701032

Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option.

P Ripellino1, C Comi, M Mula, C Varrasi, A Conconi, A Stecco, D Brustia, N Nasuelli, K Savio, L De Paoli, R Cantello, G Gaidano, F Monaco.   

Abstract

A patient with multiple myeloma was treated with high-dose chemotherapy followed by two autologous bone marrow transplantations (ABMTs). Nine months after the second ABMT the patient complained of severe left hemiparesis, paraesthesias, left homonymous visual field defects and gait ataxia. She was diagnosed with progressive multifocal leucoencephalopathy (PML) confirmed by detection of JC virus (JCV) DNA and prescribed cidofovir every other week and mirtazapine daily. Her symptoms and signs remained stable and after 6 months the JCV DNA was undetectable in the cerebrospinal fluid. Repeated MRI scans demonstrated the stabilisation of demyelinating lesion volume; after more than 2 years of follow-up the patient's neurological examination does not show significant variations. Combination of cidofovir and mirtazapine may be helpful in the treatment of PML in HIV-negative patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22701032      PMCID: PMC3079531          DOI: 10.1136/bcr.11.2010.3549

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

Review 1.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

Review 2.  Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir.

Authors:  S Osorio; R de la Cámara; N Golbano; E Marti; C G Fedele; S Nieto; R Manzanares; J M Fernández-Rañada
Journal:  Bone Marrow Transplant       Date:  2002-12       Impact factor: 5.483

3.  Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.

Authors:  B Giudici; B Vaz; S Bossolasco; S Casari; A M Brambilla; W Lüke; A Lazzarin; T Weber; P Cinque
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

4.  Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy.

Authors:  A Salmaggi; E Maccagnano; A Castagna; S Zeni; F Fantini; P Cinque; M Savoiardo
Journal:  Neurol Sci       Date:  2001-02       Impact factor: 3.307

5.  Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis.

Authors:  J F Viallard; E Lazaro; E Ellie; S Eimer; F Camou; O Caubet; M E Lafon; H Fleury; J L Pellegrin
Journal:  Infection       Date:  2007-02       Impact factor: 3.553

6.  Determinants of survival in progressive multifocal leukoencephalopathy.

Authors:  A Marzocchetti; T Tompkins; D B Clifford; R T Gandhi; S Kesari; J R Berger; D M Simpson; M Prosperi; A De Luca; I J Koralnik
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

7.  Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function.

Authors:  B O Khatri; S Man; G Giovannoni; A P Koo; J-C Lee; B Tucky; F Lynn; S Jurgensen; J Woodworth; S Goelz; P W Duda; M A Panzara; R M Ransohoff; R J Fox
Journal:  Neurology       Date:  2009-02-03       Impact factor: 9.910

8.  JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy.

Authors:  Serena Delbue; Emanuela Branchetti; Simone Bertolacci; Eleonora Tavazzi; Enrico Marchioni; Renato Maserati; Giulia Minnucci; Sara Tremolada; GianLuca Vago; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2008-11-27       Impact factor: 2.643

9.  Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy.

Authors:  M Lanzafame; S Ferrari; E Lattuada; F Corsini; R Deganello; S Vento; E Concia
Journal:  Infez Med       Date:  2009-03

10.  Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy.

Authors:  Deanna Cettomai; Justin C McArthur
Journal:  Arch Neurol       Date:  2009-02
View more
  3 in total

1.  Progressive multifocal leukoencephalopathy during ixazomib-based chemotherapy.

Authors:  C P Sawicki; S A Climans; C C Hsia; J A Fraser
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

2.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

3.  Progressive multifocal leukoencephalopathy (PML) following autologous peripheral blood stem cell transplantation for multiple myeloma.

Authors:  Karina M Bennett; Neill Storrar; Peter Johnson; Peter M Fernandes
Journal:  Clin Case Rep       Date:  2020-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.